MEASUREMENTS AND METABOLISM OF NEUROSTEROIDS IN THE CENTRAL NERVOUS SYSTEM
Project Number1Z01AA000089-04
Contact PI/Project LeaderKIM, HEE-YONG
Awardee OrganizationNATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM
Description
Abstract Text
The principal objective of this study is to determine
the effect of ethanol on the metabolism of neurosteroids in the
central nervous system. Neurosteroids such as
5a-pregnane-3a-ol-20-one (5a,3a-THP or Allopregnanolone) and
5a-pregnane-3a,21-diol-20- one (THDOC) have been shown to
modulate the GABA/benzodiazepine binding sites and to exert
anxiolytic and hypnotic effects. Modulation of these neurosteroids
in the central nervous system by ethanol may be one of the
underlying mechanisms for stress- related situations often observed
in human alcoholics during withdrawal. In the past year, we have
established a mass spectrometric technique which has adequate
sensitivity to routinely measure trace levels of neurosteroids in
cerebrospinal fluid(CSF). Specifically, GC/MS was used after
derivatizing neurosteroids with an electron capturing moiety. Using
this approach, we were able to detect pregnenolone, 5a,3a-, 5b,3a-,
5a,3b-THP, androsterone, testosterone, dihydrotestosterone and
dihydroepandrosterone from human and monkey CSF samples. We
found that human and monkey CSF contain both 5a,3a- and 5a,3b-
THP at 5-170 picogram/ml concentrations while 5b,3a-THP is
present at a concentration less than 5 pg/mL.
National Institute on Alcohol Abuse and Alcoholism
CFDA Code
DUNS Number
UEI
Project Start Date
Project End Date
Budget Start Date
Budget End Date
Project Funding Information for 1998
Total Funding
Direct Costs
Indirect Costs
Sub Projects
No Sub Projects information available for 1Z01AA000089-04
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1Z01AA000089-04
Patents
No Patents information available for 1Z01AA000089-04
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1Z01AA000089-04
Clinical Studies
No Clinical Studies information available for 1Z01AA000089-04
News and More
Related News Releases
No news release information available for 1Z01AA000089-04
History
No Historical information available for 1Z01AA000089-04
Similar Projects
No Similar Projects information available for 1Z01AA000089-04